Ovid Therapeutics Inc. (OVID) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Ovid Therapeutics Inc.

    NASDAQ: OVID · Real-Time Price · USD
    1.23
    -0.06 (-4.65%)
    At close: Sep 05, 2025, 3:59 PM
    1.21
    -1.63%
    After-hours: Sep 05, 2025, 04:50 PM EDT

    Ovid Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 566K 391.69K 1.5M 208.38M
    Cost of Revenue
    		 n/a n/a 1.38M n/a
    Gross Profit
    		 566K 392K 1.5M 208.38M
    Operating Income
    		 -61.88M -59.28M -55.55M 124.21M
    Interest Income
    		 3.9M 4.9M n/a n/a
    Pretax Income
    		 -26.43M -52.34M -54.17M 124.16M
    Net Income
    		 -26.43M -52.34M -54.17M 122.83M
    Selling & General & Admin
    		 25.68M 31.09M 32.43M 37.23M
    Research & Development
    		 36.77M 28.59M 24.62M 46.94M
    Other Expenses
    		 1K n/a n/a n/a
    Operating Expenses
    		 62.45M 59.67M 57.05M 84.17M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 62.45M 59.67M 57.05M 84.17M
    Income Tax Expense
    		 n/a n/a n/a 1.33M
    Shares Outstanding (Basic)
    		 70.91M 70.58M 70.42M 67.48M
    Shares Outstanding (Diluted)
    		 70.91M 70.58M 70.42M 68.07M
    EPS (Basic)
    		 -0.37 -0.74 -0.77 1.78
    EPS (Diluted)
    		 -0.37 -0.74 -0.77 1.76
    EBITDA
    		 -57.77M -57.01M -54.17M 124.4M
    EBIT
    		 -58.38M -57.58M -55.55M 124.16M
    Depreciation & Amortization
    		 613K 568K 1.38M 237K

    Add to Watchlist